Société Française de Toxicologie
Menu icoMenu232White icoCross32White

Ajoutez un logo, un bouton, des réseaux sociaux

Cliquez pour éditer
  • Société Française de Toxicologie
  • Actualités ▴▾
    • Actualités 2025
    • Actualités 2024
    • Actualités 2023
  • La SFT ▴▾
    • Notre histoire
    • Les statuts
    • Les membres du Bureau
  • Adhérer et cotiser ▴▾
    • Adhérer à la SFT
    • Cotiser à la SFT
  • Le congrès 2025 ▴▾
    • Sponsors
    • Le programme
    • Inscriptions
    • Posters
    • Où et quand ?
    • Photos
  • Les webinaires de la SFT ▴▾
    • 2025
    • 2024
    • 2022
    • 2021
  • Autres événements ▴▾
    • 2025
    • 2026
  • Registre Européen des toxicologues (ERT) ▴▾
    • Généralités
    • 1ère demande d'inscription
    • Renouvellement d'inscription
  • Jeunes toxicologues ▴▾
    • Bourses de congrès
    • Prix de thèse
    • CFJTox
  • Cours et formation continue ▴▾
  • Offres d'emploi ▴▾
  • Archives des congrès de la SFT ▴▾
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • Et avant...
  • Se connecter
  • Actualités 2025
  • Actualités 2024
  • Actualités 2023
  • Notre histoire
  • Les statuts
  • Les membres du Bureau
  • Adhérer à la SFT
  • Cotiser à la SFT
  • Sponsors
  • Le programme
  • Inscriptions
  • Posters
  • Où et quand ?
  • Photos
  • 2025
  • 2024
  • 2022
  • 2021
  • 2025
  • 2026
  • Généralités
  • 1ère demande d'inscription
  • Renouvellement d'inscription
  • Bourses de congrès
  • Prix de thèse
  • CFJTox
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • Et avant...
Retour

Retrospective analysis on the tolerability of commonly used vehicle....

Retrospective analysis on the tolerability of commonly used vehicle/vehicle components in rat and rabbit DART Studies

Céline Pique Bernié 1, Coralie du Peloux 1, Eulalie Nicolas 1, Edward Marsden 1

1 Charles River Laboratories Safety Assessment, Lyon, France

Vehicles, commonly used for the formulation of test items in developmental and reproductive toxicology (DART) studies, can cause significant maternal and/or developmental effects that might interfere with the interpretation of study results and the evaluation of the potential toxicity of the test item.

We have performed a retrospective analysis on vehicles used in over 400 rat and rabbit embryo-fetal (prenatal) development studies (including dose range finding and preliminary studies) conducted in the past 10 years in the authors' laboratory. The most common “non-standard” vehicle/vehicle components included cyclodextrins (e.g. Hydroxypropyl-beta-cyclodextrin), polyethylene glycol (e.g. PEG400), propylene glycol, poloxamer (e.g. Kolliphor), methylcellulose, Tween 80, oil (e.g. corn oil), lipids (e.g. Labrafil and Labrasol), used to solubilize or stabilize the active substance or as thickening agents. Vehicle/vehicle components were rated as well-tolerated or non-tolerated, based on maternal and developmental effects. Vehicle intolerability was typically characterized by lower maternal body weight gain/loss and food consumption, and excreta-related findings such as mucoid feces and/or decreased fecal output. These maternal effects may result in abortion in rabbits and secondary developmental effects such as lower fetal body weight and delay in fetal skeletal ossification both in rats and rabbits. The key factors in determining tolerability of vehicle formulations were vehicle type, vehicle quantity/proportion if used in combination with other constituents, route of administration and species.

This retrospective analysis provides valuable information to share with Sponsors when initiating DART studies, such as the acceptable no-effect range for vehicle/vehicle components in rats and rabbits. Knowledge on these vehicle-related findings can be used to try and avoid unwanted effects that can complicate the interpretation of potential test item-related effects.

Keywords: Retrospective analysis, Vehicle, Tolerability, DART studies

icoLinkedin35Color icoComment35Color
icoLinkedin35Color icoComment35Color
0 commentaire(s)
ou
Connectez-vous
Aucun commentaire pour le moment.
Consultez également
Container closure system of a drug-device combination product

Container closure system of a drug-device combination product

Biological evaluation and management of changes for a container closure system of a drug-device...

23 novembre 2025
iVEMPS: QSAR Predicting Thyroid Receptor Disruption

iVEMPS: QSAR Predicting Thyroid Receptor Disruption

iVEMPS: A High-Accuracy QSAR Predicting Thyroid Receptor Disruption as a First Step Toward...

23 novembre 2025
COSMETICK digital tool

COSMETICK digital tool

Analysis of the toxicological profiles of cosmetic ingredients and risks for cosmetic product:...

23 novembre 2025
Effects of hepatic enzyme inducers on NIS, TPO and DIO1-2-3 activities

Effects of hepatic enzyme inducers on NIS, TPO and DIO1-2-3 activities

Effects of hepatic enzyme inducers on in vitro NIS, TPO, and DIO1-2-3 activitiesAudrey Baze1,...

23 novembre 2025
Characterization of representative plasticizer exposures in NICU neonates

Characterization of representative plasticizer exposures in NICU neonates

Characterization of representative plasticizer exposures in NICU neonates using non-negative...

23 novembre 2025
NAMs for evaluating DART potential

NAMs for evaluating DART potential

New approach methodologies for evaluating DART potential: Review on state of the art,...

23 novembre 2025
Hôpital Fernand-Widal - 200 rue du faubourg Saint-Denis - 75475 Paris Cedex 10 / Contact : sft.secretariat@gmail.com
icoLinkedin24Color
  • Plan du site
  • Licences
  • Mentions légales
  • CGUV
  • Paramétrer les cookies
  • Se connecter
  • Propulsé par AssoConnect, le logiciel des associations Professionnelles